Advancing Non-Invasive Healthcare
In 2015, Nonacus was founded with a singular purpose: to offer high quality, non-invasive, genetic testing with the end-user at the forefront. Formed by a dedicated group of biotechnology professionals, Nonacus understands the need to continually deliver progress. This understanding forms the basis of all our products and drives our innovation.

Our Mission
Through the deployment of our advanced liquid biopsy platform, we will enable decentralised, cost effective and cutting-edge cancer genomics and democratise early cancer detection and monitoring globally.

Our Purpose
Detecting cancer earlier and informing patient outcomes through the deployment of a truly innovative liquid biopsy testing platform.